Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell‐mediated immunity

No abstract is available for this paper.

• Publication year

  1990

• Venue

  European Journal of Immunology

• Publication date

  1990-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/eji.1830200306PMID 2318247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins.

  1989cited by this paper
• Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix

  1987cited by this paper
• Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species.

  1987cited by this paper
• 125I-fibrin deposition in contact sensitivity reactions in the mouse. Sensitivity of the assay for quantitating reactions after active or passive sensitization.

  1986cited by this paper
• Homing Receptors and the Control of Lymphocyte Migration

  1986cited by this paper
• Reevaluation of reserpine-induced suppression of contact sensitivity. Evidence that reserpine interferes with T lymphocyte function independently of an effect on mast cells

  1985cited by this paper
• Site-selective homing of antigen-primed lymphocyte populations can play a crucial role in the efferent limb of cell-mediated immune responses in vivo.

  1985cited by this paper
• Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes.

  1985cited by this paper
• Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase

  1984cited by this paper
• Interaction of T lymphocytes and macrophages with cultured vascular endothelial cells: Attachment, invasion, and subsequent degradation of the subendothelial extracellular matrix

  1984cited by this paper
• Inhibition of delayed-type hypersensitivity by heparin depleted of anticoagulant activity.

  1983cited by this paper
• Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis.

  1983cited by this paper
• A cell-surface molecule involved in organ-specific homing of lymphocytes

  1983cited by this paper
• Heparin: an old drug with a new paradigm.

  1979cited by this paper
• Purification of the fibroblast growth factor activity from bovine brain.

  1978cited by this paper
• Stimulation of corneal endothelial cell proliferations in vitro by fibroblast and epidermal growth factors.

  1977cited by this paper
• Role of the clotting system in cell-mediated hypersensitivity. II. Kinetics of fibrinogen/fibrin accumulation and vascular permeability changes in tuberculin and cutaneous basophil hypersensitivity reactions.

  1975cited by this paper
• Effect of anticoagulants on delayed hypersensitivity reactions.

  1967cited by this paper
• Production of Lymphocytosis by Polysaccharide Polysulphates (Heparinoids)

  1967cited by this paper
• The route of re-circulation of lymphocytes in the rat

  1964cited by this paper

• The Pathophysiological Functions of Heparanases: From Evolution, Structural and Tissue‐Specific Perspectives

  2025cites this paper
• Regulatory T cells use heparanase to access IL-2 bound to extracellular matrix in inflamed tissue

  2024cites this paper
• Chemical toolbox to interrogate Heparanase-1 activity.

  2024cites this paper
• FOXP3+ regulatory T cells use heparanase to access IL-2 bound to ECM in inflamed tissues

  2023cites this paper
• Synthetic Heparanase Inhibitors Can Prevent Herpes Simplex Viral Spread.

  2023cites this paper
• Pathophysiology of reinfection by exogenous HSV-1 is driven by heparanase dysfunction

  2023cites this paper
• THE EFFICACY OF LOW-DOSE ENOXAPARIN IN PSORIASIS

  2022cites this paper
• Heparin: The Journey from Parenteral Agent to Nasal Delivery.

  2022cites this paper
• Heparanase is a regulator of natural killer cell activation and cytotoxicity

  2021cites this paper
• The Heparanase Regulatory Network in Health and Disease

  2021cites this paper
• Glycosylation changes in inflammatory diseases.

  2020cites this paper
• Thrombolytic Agents: Nanocarriers in Controlled Release.

  2020cites this paper
• Role of Heparanase in tumor progression: molecular aspects and therapeutic options.

  2020cites this paper
• Mechanism of HPSE Gene SNPs Function: From Normal Processes to Inflammation, Cancerogenesis and Tumor Progression.

  2020cites this paper
• Non-anticoagulant heparins

  2020cites this paper
• Leukocyte Heparanase: A Double-Edged Sword in Tumor Progression

  2019cites this paper
• Neutrophil extracellular traps (NETs) contribute to pathological changes of ocular graft-vs.-host disease (oGVHD) dry eye: Implications for novel biomarkers and therapeutic strategies.

  2019cites this paper
• Comparative evaluation of oral corticosteroids versus low molecular weight heparin in the treatment of lichen planus

  2019cites this paper
• Matrix by Nonpeptidic Mimetics of Arg-GIy-Asp

  2018cites this paper
• An Update on Immunotherapy for Solid Tumors: A Review

  2018cites this paper
• The Role of Heparan Sulfate in Inflammation, and the Development of Biomimetics as Anti-Inflammatory Strategies

  2018cites this paper
• Glycan distribution and density in native skin's stratum corneum

  2018cites this paper
• Mechanisms regulating T-cell infiltration and activity in solid tumors.

  2017cites this paper
• Recovery From Amiodarone-Induced Cornea Verticillata by Application of Topical Heparin

  2017cites this paper
• Microbial metabolites and derivatives targeted at inflammation and bone diseases therapy: chemistry, biological activity and pharmacology

  2017cites this paper
• Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy

  2017cites this paper
• Heparanase: Potential roles in multiple sclerosis.

  2017cites this paper
• Heparanase is required for activation and function of macrophages

  2016cites this paper
• Heparanase: From basic research to therapeutic applications in cancer and inflammation.

  2016cites this paper
• vivo by promoting adhesion to vascular endothelium Heparanase induces inflammatory cell recruitment in

  2016cites this paper
• Pharmacology of Heparin and Related Drugs

  2016influential citation
• The Role of Heparanase in Pulmonary Cell Recruitment in Response to an Allergic but Not Non-Allergic Stimulus

  2015cites this paper
• Nanocarriers in Improved Heparin Delivery: Recent Updates.

  2015cites this paper
• Heparanase of murine effector lymphocytes and neutrophils is not required for their diapedesis into sites of inflammation

  2015cites this paper
• heparins on allergic airway responses Molecular-weight-dependent effects of nonanticoagulant

  2015cites this paper
• Heparan Sulfate Proteoglycan Metabolism and the Fate of Grafted Tissues.

  2015cites this paper
• Non-anticoagulant derivatives of heparin for the management of asthma: distant dream or close reality?

  2014influential citation
• Expression de l'héparanase dans des lymphocytes t humains

  2014cites this paper
• Role of ICAM-1 in the aggregation and adhesion of human alveolar macrophages in response to TNF-a and INF-g

  2014cites this paper
• Heparanase induces inflammatory cell recruitment in vivo by promoting adhesion to vascular endothelium.

  2014cites this paper
• Versatile role of heparanase in inflammation.

  2013cites this paper
• Heparin Treatment for Allergic Conjunctivitis in the Experimental Balb/c Model

  2013cites this paper
• Heparin and Related Drugs: Beyond Anticoagulant Activity

  2013cites this paper
• Heparanase in inflammation and inflammation‐associated cancer

  2013cites this paper
• The effectiveness of treatment with enoxaparin in lichen planus

  2012cites this paper
• Salmon proteoglycan suppresses progression of mouse experimental autoimmune encephalomyelitis via regulation of Th17 and Foxp3(+) regulatory T cells.

  2012cites this paper
• Heparin - A Century of Progress

  2012cites this paper
• Inhibition of allergic airway responses by heparin derived oligosaccharides: identification of a tetrasaccharide sequence

  2012cites this paper
• Heparanase enzyme in chronic inflammatory bowel disease and colon cancer

  2012cites this paper
• Non-anticoagulant effects of heparin: an overview.

  2012cites this paper
• Treatment of Recalcitrant Lichen Planus with Low Molecular Weight Heparin (Enoxaparin): A Case Series Study among Iraqi Patients

  2011cites this paper
• Critical parameters in blood processing for T-cell assays: validation on ELISpot and tetramer platforms.

  2010cites this paper
• Low-molecular-weight heparins do not modify obliterative airway disease in rat tracheal allografts

  2010cites this paper
• Heparin: an intervenor in cell communication

  2009cites this paper
• Cell Surface-expressed Cation-independent Mannose 6-Phosphate Receptor (CD222) Binds Enzymatically Active Heparanase Independently of Mannose 6-Phosphate to Promote Extracellular Matrix Degradation*

  2008cites this paper
• Trophoblast-derived heparanase is not required for invasion.

  2008cites this paper
• Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.

  2007cites this paper
• Heparin and EDTA as anticoagulant differentially affect cytokine mRNA level of cultured porcine blood cells.

  2007cites this paper
• Expression of the heparan sulfate‐degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene

  2007cites this paper
• Award Number: W81XWH-04-1-0235 TITLE: Involvement and Regulation of Heparanase in Prostate Cancer Progression PRINCIPAL INVESTIGATOR: Dr. Michael Elkin CONTRACTING ORGANIZATION: Hadassah Medical Organization

  2007cites this paper
• Allergic rhinitis and its pharmacology.

  2007cites this paper
• STUDIES ON DRUG ELUTING STENTS IN PREVENTION OF RENAL ARTERY STENOSIS IN DOGS

  2007cites this paper
• Salmon cartilage proteoglycan modulates cytokine responses to Escherichia coli in mouse macrophages.

  2006cites this paper
• Evaluation of Guinea pig models of the acute phase of allergic rhinitis

  2006cites this paper
• Structural requirements of heparin and related molecules to exert a multitude of anti-inflammatory activities.

  2006cites this paper
• Involvement and Regulation of Heparanase in Prostate Cancer Progression

  2006cites this paper
• Role of endothelial heparanase in delayed-type hypersensitivity.

  2006cites this paper
• Dendritic Cells Monocyte-Derived Transmigration of Mature Extracellular Matrix Heparan Sulfate upon Surface Regulates Degradation of Translocation of Active Heparanase to Cell

  2006cites this paper
• Translocation of Active Heparanase to Cell Surface Regulates Degradation of Extracellular Matrix Heparan Sulfate upon Transmigration of Mature Monocyte-Derived Dendritic Cells1

  2006cites this paper
• The role of heparan sulphate in inflammation

  2006cites this paper
• Chondroitin sulfate proteoglycan and its degradation products in CNS repair.

  2006cites this paper
• Role of endothelial heparanase in delayed-type hypersensitivity

  2005cites this paper
• The management of lichen planus with low‐molecular‐weight heparin (enoxaparin)

  2005cites this paper
• Glycosaminoglycan: a candidate to stimulate the repair of chronic wounds

  2005cites this paper
• Anticoagulation in sepsis: Is low-dose heparin as effective as activated protein C?

  2005cites this paper
• Effects of bemiparin on airway responses to antigen in sensitized Brown-Norway rats.

  2005cites this paper
• Heparin‐disaccharide affects T cells: inhibition of NF‐κB activation, cell migration, and modulation of intracellular signaling

  2004cites this paper
• Inhibitory effect of heparin-derived oligosaccharides on secretion of interleukin-4 and interleukin-5 from human peripheral blood T lymphocytes.

  2004cites this paper
• Important Role in Immune Response Cu/Zn Superoxide Dismutase Plays

  2003cites this paper
• Transplant immunobiology: a crucial role for heparan sulfate glycosaminoglycans?

  2003cites this paper
• A synthetic heparin-mimicking polyanionic compound inhibits central nervous system inflammation.

  2003cites this paper
• Alternate treatments in asthma.

  2003cites this paper
• Heparin inhibits lipopolysaccharide (LPS) binding to leukocytes and LPS-induced cytokine production.

  2003cites this paper
• Novel approaches in the treatment of allergic rhinitis

  2003cites this paper
• Cu/Zn Superoxide Dismutase Plays Important Role in Immune Response

  2003cites this paper
• Role of the microenvironment in immune responses to transplantation

  2003cites this paper
• Syndecans in inflammation

  2003cites this paper
• Cu/Zn Superoxide Dismutase Plays Important Role in Immune Response1

  2003cites this paper
• Heparin inhibits hyperventilation-induced late-phase hyperreactivity in dogs.

  2002cites this paper
• Novel drug development opportunities for heparin

  2002cites this paper
• Low molecular weight heparin aggravates infectious arthritis triggered by Staphylococcus aureus

  2002cites this paper
• Activation of EphB2 and Its Ligands Promotes Vascular Smooth Muscle Cell Proliferation*

  2002cites this paper
• Miscellaneous treatments, II: niacin and heparin: unapproved uses, dosages, or indications.

  2002cites this paper
• Rodent mast cell characteristics MAST CELLS 1035 Characteristics Peritoneal Cavity Mast Cell Intestinal Mucosa Mast Cell Alternative names Size Formaldehyde fixation Staining T-cell dependence in development Protease content Proteoglycans molecular mass Histamine 5-Hydroxytryptamine Prostaglandin

  2002cites this paper
• Role of syndecan-1 in leukocyte-endothelial interactions in the ocular vasculature.

  2002cites this paper
• Role of ICAM-1 in the aggregation and adhesion of human alveolar macrophages in response to TNF-alpha and INF-gamma.

  2001cites this paper
• Glycosaminoglycans, airways inflammation and bronchial hyperresponsiveness.

  2001cites this paper
• Treatment of chronic renal allograft rejection in rats with a low-molecular-weight heparin (reviparin).

  2001cites this paper
• Low Molecular Weight Heparin Reduces Proteinuria and Modulates Glomerular TNF-α Production in the Early Phase of Adriamycin Nephropathy

  2001cites this paper
• Oral Heparin Prevents Neointimal Hyperplasia After Arterial Injury: Inhibitory Potential Depends on Type of Vascular Injury

  2001cites this paper